Skip to main content

CEPI announces new partnerships with AstraZeneca and CSL, Australia to manufacture millions of doses of COVID-19 vaccine candidates | The AAS


Country
Regional
Language
English
Region
Africa
Resource type
Related links

Powered by
IPARD

More on this